Douglas Veale comments on study results showing that secukinumab-treated PsA patients have low rates of radiographic progression regardless of prior TNF inhibitor exposure or concomitant methotrexate treatment (2:45).
19-06-2018 | Psoriatic arthritis | EULAR 2018 | Video